Skip to content

Response to EC consultation on Orphan Medicinal Products

 

 

The Society had contributed to the Royal College of Physicians' response to the European Commission consultation on orphan medicinal products via the Joint Speciality Committee for Clinical Pharmacology and Therapeutics (a partnership between the British Pharmacological Society and the Royal College of Physicians).

 

Latest consultation responses

The Good Clinical Trials Collaborative published new draft guidance for Randomized Controlled Trials (RCT). This guidance was developed in partnership…

 

 

In June 2021, the Department of Health & Social Care opened a call for evidence to inform their Women’s Health Strategy. In the…

 

 

The Nuffield Council on Bioethics recently launched a new in-depth project on the future of ageing. Within this, was a consultation…